Bleomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9241

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bleomycin (NDC 0143-9241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Bleomycin For Injection Usp 1)

Chemical structure of the active ingredient Bleomycin, showing the detailed molecular components and side chains of the main component Bleomycin A2.*

FDA Label Image

Bleomycin 15 Units/vial (Bleomycin For Injection Usp 2)

Bleomycin 15 units per vial injection, powder, lyophilized for solution. The label states each vial contains sterile bleomycin sulfate equivalent to 15 units of bleomycin. Intended for intramuscular, intravenous, subcutaneous, or intrapleural use. The label also includes storage instructions to keep the dry powder refrigerated at 2° to 8°C (36° to 46°F). Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*

FDA Label Image

Bleomycin For Injection 30 Units/vial (Bleomycin For Injection Usp 3)

Bleomycin for Injection, USP 15 units per vial powder label. The label indicates sterile bleomycin sulfate for intramuscular, intravenous, subcutaneous, or intrapleural use. It includes manufacturer info (Thymoorgan Pharmazie GmbH, Germany) and distributor info (Hikma Pharmaceuticals USA Inc.). Instructions include storage between 2° to 8°C and a caution for cytotoxic special handling procedures.*

FDA Label Image

Representative Carton Serialization Image (Bleomycin For Injection Usp 4)

Bleomycin for Injection, USP powder vial label by Hikma Pharmaceuticals USA Inc. The label states each vial contains sterile bleomycin sulfate equivalent to 30 units of bleomycin. It is for injection via IM, IV, SC, or intrapleural routes. The label includes storage instructions and manufacturer information from Thymoorgan Pharmazie GmbH, Germany.*

FDA Label Image

Bleomycin For Injection Usp 5

Bleomycin for Injection, USP 30 units per vial powder label. The label is for a single dose vial containing lyophilized powder. It is manufactured by THYMOORGAN PHARMAZIE GmbH and distributed by Hikma Pharmaceuticals USA Inc. The label provides storage instructions and warns of cytotoxicity with special handling procedures. Routes of administration noted include intramuscular, intravenous, subcutaneous, and intrapleural.*

FDA Label Image

Bleomycin For Injection Usp 6

The label for Bleomycin injection powder, lyophilized, for solution, displays a Data Matrix barcode, lot number ABCDE12345, an expiration date placeholder in MMMYYYY format, and identifiers including GTIN 00301234567896 and serial number 12345678901234. The label aligns with products from Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.